Document Detail


In vitro effect of suramin on lung tumour cells.
MedLine Citation:
PMID:  8422289     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
In the search for new therapeutic concepts in lung cancer chemotherapy, suramin, a potential anticancer drug which evades multidrug resistance, was tested in vitro on 25 lung-derived cell lines, either non-tumorigenic cells, or established cell lines from five different tumour types. Suramin treatment resulted in a time- and dose-dependent decrease in [3H]thymidine incorporation, except in one adenocarcinoma cell line where DNA synthesis was highly stimulated. [3H]Leucine incorporation was less affected, indicating that suramin acted cytostatically rather than cytotoxically. Our results show that suramin affected DNA synthesis of the different types of lung derived cells, including non-tumorigenic and tumour cell lines, to a similar extent.
Authors:
I A Mórocz; B Lauber; D Schmitter; R A Stahel
Related Documents :
9292749 - Arcon--current status: summary of a workshop on preclinical and clinical studies.
6147359 - Amine and peptide hormone production by lung carcinoid: a clinicopathological and immun...
10668919 - Dendritic cell immunotherapy induces antitumour response in parathyroid carcinoma and n...
21234809 - Tuning of cd40-cd154 interactions in human b-lymphocyte activation: a broad array of in...
18217949 - Generation and characterization of transgenic mice expressing a t-cell receptor specifi...
15258459 - Id-1 expression and cell survival.
17658699 - Pyothorax-associated lymphoma: a case showing transition from t-cell-rich polymorphic l...
18178159 - T cell precursor frequency differentially affects ctl responses under different immune ...
23422749 - Overexpression of mir-155 causes expansion, arrest in terminal differentiation and func...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  European journal of cancer (Oxford, England : 1990)     Volume:  29A     ISSN:  0959-8049     ISO Abbreviation:  Eur. J. Cancer     Publication Date:  1993  
Date Detail:
Created Date:  1993-02-23     Completed Date:  1993-02-23     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  9005373     Medline TA:  Eur J Cancer     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  245-7     Citation Subset:  IM    
Affiliation:
Department of Medicine, University Hospital, Zürich, Switzerland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
DNA, Neoplasm / biosynthesis
Dose-Response Relationship, Drug
Drug Screening Assays, Antitumor
Humans
Leucine / metabolism
Lung Neoplasms / drug therapy*,  metabolism
Suramin / therapeutic use*
Thymidine / metabolism
Time Factors
Tumor Cells, Cultured / drug effects
Chemical
Reg. No./Substance:
0/DNA, Neoplasm; 145-63-1/Suramin; 50-89-5/Thymidine; 61-90-5/Leucine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  MHC class I expression on prelymphomatous and lymphomatous B-cells is not inhibited by an E mu-myc t...
Next Document:  Oestrogen receptor message in premalignant and normal cervical cells: a methodological study.